RCKT
ROCKET PHARMACEUTICALS, INC. · Healthcare · Market cap $241.5M
Insiders sold $432K net in the last 90 days ·4 sellers, 0 buyers· latest Form 4 filed Sep 16, 2026
Insider Buying
$34K
reported purchases (SEC code P)
Insider Selling
$864K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Sep 16, 2026
Wilson Martin
ROCKET PHARMACEUTICALS, INC. (RCKT) has 41 SEC Form 4 filings (42 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Sep 16, 2026.
Inside the rolling window, 7 insiders at ROCKET PHARMACEUTICALS, INC. reported 1 open-market purchase totaling $34K and 25 open-market sales totaling $864K. The most active filer is General Counsel Wilson Martin with 8 filings. Insiders have net sold $708K over the trailing 6 months. The most recent open-market filing is a sale of 75,364 shares by General Counsel Wilson Martin, dated Sep 11, 2026, worth $256K.
- Industry:Biotechnology
- CEO:Gaurav D. Shah
- Employees:202
- HQ:Cranbury, NJ, US
- IPO:2015-02-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
| General Counsel | Sale | 75,364 | $256K | Sep 16 | -36.8% | SEC ↗ | |
| General Counsel | Sale | 631 | $2K | Aug 20 | -36.8% | SEC ↗ | |
| CEO | Sale | 2,293 | $8K | Aug 20 | -36.8% | SEC ↗ | |
| CEO | Sale | 2,837 | $10K | Aug 17 | -35.3% | SEC ↗ | |
| General Counsel | Sale | 3,493 | $12K | Aug 17 | -35.3% | SEC ↗ | |
Chaudhuri SarbaniFirst in 3 months | See Remarks | Sale | 4,701 | $16K | Aug 13 | -34.1% | SEC ↗ |
Stevens Christopher JamesFirst filing | Chief Operating Officer | Sale | 36,658 | $128K | Aug 13 | -34.1% | SEC ↗ |
| CEO | Sale | 55,684 | $172K | May 26 | -26.7% | SEC ↗ | |
| CEO | Sale | 2,409 | $7K | May 21 | -29.3% | SEC ↗ | |
| General Counsel | Sale | 662 | $2K | May 21 | -29.3% | SEC ↗ | |
| See Remarks | Sale | 384 | $1K | May 21 | — | SEC ↗ | |
| General Counsel | Sale | 3,361 | $12K | May 14 | — | SEC ↗ | |
| See Remarks | Sale | 855 | $3K | May 14 | — | SEC ↗ | |
| CEO | Sale | 2,728 | $10K | May 14 | — | SEC ↗ | |
Chaudhuri SarbaniFirst filing | See Remarks | Sale | 17,650 | $68K | May 11 | — | SEC ↗ |
| CEO | Sale | 5,990 | $20K | Feb 20 | — | SEC ↗ | |
| See Remarks | Sale | 1,157 | $4K | Feb 20 | — | SEC ↗ | |
| General Counsel | Sale | 1,376 | $5K | Feb 20 | — | SEC ↗ | |
Wilson MartinFirst in 3 months | General Counsel | Sale | 12,253 | $41K | Feb 18 | — | SEC ↗ |
Militello JohnFirst in 3 months | See Remarks | Sale | 3,726 | $12K | Feb 18 | — | SEC ↗ |
Shah GauravFirst in 3 months | CEO | Sale | 12,279 | $41K | Feb 18 | — | SEC ↗ |
Bjork ElisabethFirst filing | Director | Purchase | 10,000 | $34K | Jan 6 | — | SEC ↗ |
Schwartz Jonathan DavidFirst filing | See Remarks | Sale | 2,545 | $8K | Nov 20 | — | SEC ↗ |
Wilson MartinFirst filing | General Counsel | Sale | 1,646 | $5K | Nov 20 | — | SEC ↗ |
Militello JohnFirst filing | See Remarks | Sale | 1,086 | $3K | Nov 20 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does RCKT have?
ROCKET PHARMACEUTICALS, INC. (RCKT) has 41 SEC Form 4 filings (42 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Sep 16, 2026.
When was the most recent SEC Form 4 filing for RCKT?
The most recent Form 4 filing for RCKT on Tracefour is dated Sep 16, 2026.
Who is the most active insider at RCKT?
The most active SEC Form 4 filer at RCKT in the rolling window is General Counsel Wilson Martin, with 8 filings.
What is the net insider flow at RCKT over the last 6 months?
Over the trailing 180 days, insiders at RCKT have net sold $708K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at RCKT in the current window?
Inside the rolling window, insiders at RCKT bought $34K and sold $864K based on SEC Form 4 filings.
Can I get alerts for RCKT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ROCKET PHARMACEUTICALS, INC. (RCKT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ROCKET PHARMACEUTICALS, INC. is in the Healthcare sector.